Sign in
8-K

Current Report

Niagen Bioscience, Inc. Filed Acc 0001415889-16-005075

Regulation FD disclosure · Other events

  • Item 7.01 Regulation FD disclosure
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading cdxc8k_mar152016.htm…